KATHMANDU: The Department of Drug Administration (DDA) has issued a notice directing the recall of Levoflox-500 tablets from the market. The recall applies specifically to tablets bearing batch number BB-24001.
The Department has instructed all concerned parties not to recommend, sell, distribute, or use the medicine from this batch. Manufactured by Magnus Pharma Pvt. Ltd., Levoflox-500 is commonly used to treat bacterial infections.
According to the DDA, laboratory tests conducted at the National Drug Laboratory found that the specified batch failed to meet required quality standards. As a result, the sale and distribution of the drug have been suspended, and all stocks must be immediately withdrawn from the market.
The Department has further directed the concerned manufacturer and its representatives to submit recall records in accordance with Section 14 of the Drug Act, 2035 BS, as stated in the notice.
Comment